What is he best known for?
The fields of study he is best known for:
Isidro Sánchez-García mainly focuses on Cell biology, Cancer research, Oncogene, Genetics and Stem cell.
His research in Cell biology intersects with topics in Epithelial–mesenchymal transition, Cell migration, Fusion gene, Cell cycle and Regulation of gene expression.
The study incorporates disciplines such as Chronic myelogenous leukemia, breakpoint cluster region, Transgene and Chromosomal translocation in addition to Cancer research.
His Oncogene study is associated with Cancer.
His work in Genetics addresses issues such as Slug, which are connected to fields such as Waardenburg syndrome, Microphthalmia-associated transcription factor, Gene interaction, Neural crest and Microphthalmia.
His work carried out in the field of Stem cell brings together such families of science as Zinc finger transcription factor and Immunology.
His most cited work include:
- The LIM domain: a new structural motif found in zinc-finger-like proteins. (296 citations)
- In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence (291 citations)
- Binding proteins for recognition of DNA (288 citations)
What are the main themes of his work throughout his whole career to date?
Isidro Sánchez-García focuses on Cancer research, Cancer, Stem cell, Cancer stem cell and Cell biology.
The concepts of his Cancer research study are interwoven with issues in Haematopoiesis, Progenitor cell, Carcinogenesis, Oncogene and breakpoint cluster region.
His Cancer research is multidisciplinary, relying on both Clinical trial, Bioinformatics, Oncology and Intensive care medicine.
Isidro Sánchez-García has researched Stem cell in several fields, including Cellular differentiation, Cancer cell, Reprogramming and Leukemia, Immunology.
His studies deal with areas such as Myeloid leukemia, Disease and Drug discovery as well as Cancer stem cell.
The various areas that he examines in his Cell biology study include Cell, Regulation of gene expression and Transcription factor.
He most often published in these fields:
- Cancer research (42.53%)
- Cancer (25.29%)
- Stem cell (25.29%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (42.53%)
- Stem cell (25.29%)
- Leukemia (13.22%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Stem cell, Leukemia, Cancer and Haematopoiesis.
His Cancer research research incorporates elements of Cell culture, Germinal center, LMO2 and Diffuse large B-cell lymphoma.
His Stem cell study improves the overall literature in Cell biology.
His Cell biology research includes themes of Acquired immune system and B cell.
His work in the fields of Cancer, such as Cancer stem cell, intersects with other areas such as Relative survival and Drug development.
Isidro Sánchez-García interconnects Progenitor cell and breakpoint cluster region in the investigation of issues within Haematopoiesis.
Between 2017 and 2021, his most popular works were:
- Epigenetic Priming in Cancer Initiation. (38 citations)
- Loss of Pax5 Exploits Sca1-BCR-ABLp190 Susceptibility to Confer the Metabolic Shift Essential for pB-ALL. (19 citations)
- Lmo2 expression defines tumor cell identity during T-cell leukemogenesis (17 citations)
In his most recent research, the most cited papers focused on:
Isidro Sánchez-García spends much of his time researching Haematopoiesis, Cancer research, Reprogramming, Progenitor cell and Immunology.
His Haematopoiesis study results in a more complete grasp of Cell biology.
He has included themes like Synthetic lethality, DNA damage, Homologous recombination, B cell and Poly ADP ribose polymerase in his Cancer research study.
His Reprogramming research integrates issues from Cancer stem cell, Stem cell, Priming, Tumor progression and Epigenetics.
His research integrates issues of HEK 293 cells, Cell culture, Cord blood, Transcriptome and breakpoint cluster region in his study of Progenitor cell.
His Immunology research incorporates themes from Ex vivo and Gene expression profiling.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
